definiens: means ( a ) all movement disorders described in WHO ICD-10 ( G20 - G26 ) and/or in [COMPANY] ’ published International PCT Patent Application WO 2 008/119057 A2, including, without limitation, Parkinson ’s Disease, Restless Legs Syndrome, Post - e ncephalitic Parkinsonism, Dopamine - Responsive Dystonia, Shy - Drager Syndrome, Periodic Limb Moveme nt Disorder, Periodic Limb Movements in Sleep, Tourette ’s Syndrome, all other movement diso rders treatable with a dopamine receptor agonist or a † DESIGNATES PORTIONS OF THIS DOCUMENT THAT HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT FILED SEPARATELY WITH THE COMMISSION precursor of a dopamine receptor agonist [ † ] ( colle ctively ), ( b ) all addiction and compulsive disorders described in WHO ICD-10 ( F10 - F19, F40 - F48, F50 - F59 ) and/or in [COMPANY] ’ published International PCT Patent Applicat ion WO 2012/064667A2 A2 ( collectively ), and ( c ) all other diseases except ( i ) those des cribed in above ( a ) and ( b ) and ( ii ) diseases in the dermatology and dermatologic a ffections defined as any disease of the skin, the hair / scalp and nails ( collectively ) . ” 2 Milestone Payments Sections 3.1 and 3.2 of the Agreement are amended a nd restated in their entirety to read as follows : ) in U.S. dollars following the satisfaction of the following corresp onding milestone events ( each a )